Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent Litigation
15 févr. 2023 16h15 HE
|
Conformis, Inc.
BILLERICA, Mass., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) along with Bodycad Laboratories, Inc. and Bodycad USA Corp. announced today that they have entered into a settlement...
Conformis Provides Business Update and Reports Preliminary Results for Fourth Quarter and Full-Year 2022
10 févr. 2023 07h00 HE
|
Conformis, Inc.
BILLERICA, Mass., Feb. 10, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, provided today a...
Conformis, Inc. to Announce Financial Results for Its Fourth Quarter and Full-Year 2022
23 janv. 2023 16h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it...
Conformis, Inc. Regains Compliance with Nasdaq’s Minimum Bid Price Rule
30 nov. 2022 16h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it received a letter from the Listing Qualifications Department of The NASDAQ Stock Market...
Conformis Announces First Procedure Performed Using New Actera™ Hip System
29 nov. 2022 07h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical device company that features personalized knee and hip replacement products, today announced that...
Conformis Announces Full Commercial Launch of Imprint™
17 nov. 2022 07h00 HE
|
Conformis, Inc.
BILLERICA, Mass., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, today announced the...
Conformis, Inc. Announces Settlement of Medacta Patent Litigation
14 nov. 2022 16h15 HE
|
Conformis, Inc.
BILLERICA, Mass., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a settlement and license agreement with Medacta USA, Medacta Germany GmbH,...
Conformis, Inc. Effects 1-for-25 Reverse Stock Split
09 nov. 2022 07h00 HE
|
Conformis, Inc.
BILLERICA, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) (“Conformis”) announced that it will effect a 1-for-25 reverse stock split at 5:00 p.m. Eastern time today....
Conformis Reports Third Quarter 2022 Financial Results
02 nov. 2022 16h10 HE
|
Conformis, Inc.
BILLERICA, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis, Inc. to Announce Financial Results for Its Third Quarter 2022
05 oct. 2022 16h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it...